250 related articles for article (PubMed ID: 15362047)
21. CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C.
Nitschke K; Luxenburger H; Kiraithe MM; Thimme R; Neumann-Haefelin C
Dig Dis; 2016; 34(4):396-409. PubMed ID: 27170395
[TBL] [Abstract][Full Text] [Related]
22. Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection.
Lancaster T; Sanders E; Christie JM; Brooks C; Green S; Rosenberg WM
J Viral Hepat; 2002 Jan; 9(1):18-28. PubMed ID: 11851899
[TBL] [Abstract][Full Text] [Related]
23. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
24. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
[TBL] [Abstract][Full Text] [Related]
25. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
26. Broadening CD4
Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
[TBL] [Abstract][Full Text] [Related]
27. Immunopathogenesis of hepatitis C virus infection.
Chang KM
Clin Liver Dis; 2003 Feb; 7(1):89-105. PubMed ID: 12691460
[TBL] [Abstract][Full Text] [Related]
28. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM
Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870
[TBL] [Abstract][Full Text] [Related]
29. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.
Lauer GM; Lucas M; Timm J; Ouchi K; Kim AY; Day CL; Schulze Zur Wiesch J; Paranhos-Baccala G; Sheridan I; Casson DR; Reiser M; Gandhi RT; Li B; Allen TM; Chung RT; Klenerman P; Walker BD
J Virol; 2005 Oct; 79(20):12979-88. PubMed ID: 16189000
[TBL] [Abstract][Full Text] [Related]
30. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.
Schulze Zur Wiesch J; Ciuffreda D; Lewis-Ximenez L; Kasprowicz V; Nolan BE; Streeck H; Aneja J; Reyor LL; Allen TM; Lohse AW; McGovern B; Chung RT; Kwok WW; Kim AY; Lauer GM
J Exp Med; 2012 Jan; 209(1):61-75. PubMed ID: 22213804
[TBL] [Abstract][Full Text] [Related]
31. Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
Martin P; Parroche P; Pajot A; Chatel L; Barreto C; Touat L; Dubois V; Rohrlich PS; Bain C; Trépo C; Negro F; Inchauspé G; Fournillier A
Microbes Infect; 2006 Aug; 8(9-10):2432-41. PubMed ID: 16859951
[TBL] [Abstract][Full Text] [Related]
32. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes.
Schulze zur Wiesch J; Lauer GM; Day CL; Kim AY; Ouchi K; Duncan JE; Wurcel AG; Timm J; Jones AM; Mothe B; Allen TM; McGovern B; Lewis-Ximenez L; Sidney J; Sette A; Chung RT; Walker BD
J Immunol; 2005 Sep; 175(6):3603-13. PubMed ID: 16148104
[TBL] [Abstract][Full Text] [Related]
33. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.
Gruener NH; Lechner F; Jung MC; Diepolder H; Gerlach T; Lauer G; Walker B; Sullivan J; Phillips R; Pape GR; Klenerman P
J Virol; 2001 Jun; 75(12):5550-8. PubMed ID: 11356962
[TBL] [Abstract][Full Text] [Related]
34. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.
Day CL; Lauer GM; Robbins GK; McGovern B; Wurcel AG; Gandhi RT; Chung RT; Walker BD
J Virol; 2002 Dec; 76(24):12584-95. PubMed ID: 12438584
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
Neumann-Haefelin C; Timm J; Schmidt J; Kersting N; Fitzmaurice K; Oniangue-Ndza C; Kemper MN; Humphreys I; McKiernan S; Kelleher D; Lohmann V; Bowness P; Huzly D; Rosen HR; Kim AY; Lauer GM; Allen TM; Barnes E; Roggendorf M; Blum HE; Thimme R
Hepatology; 2010 Jan; 51(1):54-62. PubMed ID: 20034048
[TBL] [Abstract][Full Text] [Related]
36. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.
Lucas M; Vargas-Cuero AL; Lauer GM; Barnes E; Willberg CB; Semmo N; Walker BD; Phillips R; Klenerman P
J Immunol; 2004 Feb; 172(3):1744-53. PubMed ID: 14734757
[TBL] [Abstract][Full Text] [Related]
37. The role of immune responses in the pathogenesis of hepatitis C virus infection.
Koziel MJ
J Viral Hepat; 1997; 4 Suppl 2():31-41. PubMed ID: 9429208
[TBL] [Abstract][Full Text] [Related]
38. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
[TBL] [Abstract][Full Text] [Related]
40. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
